IL ‑6 plays a crucial role in epithelial‑mesenchymal transition and pro‑metastasis induced by sorafenib in liver cancer.

In conclusion, the present results indicated that IL‑6/STAT3 signaling may be a novel therapeutic strategy for liver cancer. PMID: 33432366 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33432366?dopt=Abstract

Source: Oncology Reports - January 13, 2021 Category: Cancer & Oncology Tags: Oncol Rep Source Type: research